about
Erythropoiesis-stimulating agents for anaemia in chronic heart failure patientsHIF prolyl hydroxylase inhibitors for anemiaHigher doses of erythropoietin-stimulating agents and hyporesponsiveness to their effects are associated with increased mortality among prevalent hemodialysis patients.Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal diseaseOncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients.Erythropoietin-induced erythroid precursor pool depletion causes erythropoietin hyporesponsiveness.Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects.Associates of cardiopulmonary arrest in the perihemodialytic period.Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristicsErythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients.Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST)Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats.The effect of Vitamin D administration on treatment of anemia in end-stage renal disease patients with Vitamin D deficiency on hemodialysis: A placebo-controlled, double-blind clinical trial.Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis PatientsIron Balance and the Role of Hepcidin in Chronic Kidney DiseaseNotch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice.Prevention of access-related infection in dialysis.Resistance to erythropoiesis-stimulating agents is associated with arterial microcalcification in early hemodialysis patients.Treatment with calcimimetic (cinacalcet) alters epoetin dosage requirements in dialysis patients: preliminary report.Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements.Iron as the key modulator of hepcidin expression in erythroid antibody-mediated hypoplasia.Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study.Erythropoiesis-stimulating agent hyporesponsiveness in dialysis patients: be aware of subclinical hypothyroidism.Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies.Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study.Association of Neutrophil-to-Lymphocyte Ratio With Inflammation and Erythropoietin Resistance in Chronic Dialysis Patients.Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.Temporal changes in physiology and haematology in response to high- and micro-doses of recombinant human erythropoietin.Influence of combined iron supplementation and simulated hypoxia on the haematological module of the athlete biological passport.Hydroxocobalamin supplementation and erythropoisis stimulating agent hyporesponsiveness in haemodialysis patients.Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease.A patient undergoing chronic dialysis whose renal anemia was successfully corrected by treatment with cinacalcet.Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol.A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease.
P2860
Q24241045-EA944505-E2AE-498E-8A6F-77688CCD795AQ28307377-62626820-5AA1-42C8-A6AF-3457FE103A4EQ30456721-B1C38FF1-3543-402F-9B7F-74F0BB9D53CCQ33532601-406A1A5E-757E-4FA6-8F63-FDD14ECC911DQ33625452-F23FB99E-99AD-46ED-A903-89A15503AB8BQ33655326-FAEBE0B1-7C0D-44E6-954C-495854ED1B48Q34505760-F4B684A2-C066-4C3A-AFF3-5A33BDD752DAQ34532711-9DB66C40-0506-4D88-B3C6-D1FBECB4157AQ34593321-9ED2F20D-39F3-459F-B243-24AC461C06CAQ34997753-28AF00B8-129A-491B-A2D7-03DF09750F94Q35151878-9088A24F-00D5-4D45-86AA-636E7D0E124DQ35978103-9A47C72C-5ABE-4EC4-9587-EC40DFB266A8Q36298298-7140CECC-982F-43FA-AC02-358C638DA463Q36746098-D14A5ED7-91FB-48B0-85A6-0B7004BA27FEQ36945750-A86C3904-D3C9-4DE8-A20A-6B114E1ADF10Q37559382-01F2EDB2-C52C-4B5E-9D03-1A4059A93C84Q37646705-591763E6-E321-4AE1-A901-A68AAAE393E4Q37687219-11DDB653-ED0F-4D70-81E0-614C8B431D6EQ37889300-A522013C-24C0-4561-B0F9-03E41102B063Q38740776-45EC75F9-488D-4EE1-99C7-B6F46C999CBBQ41858575-4D0D3016-83F3-4793-A767-E754EE168A05Q42180857-31F11514-E7D5-4FC2-A920-BEC38B881057Q43064681-534015EB-A4F4-4A55-9485-19E653294688Q43426045-129990B7-177F-4C1F-9B3D-217CCBBEE48AQ43446487-0BA14A65-886C-4487-9DD2-C83718F31800Q46252452-4498207C-D393-432C-9F29-A6E4820A4955Q46523502-FAAAB658-7D5A-4A94-A108-1D072154EF52Q47103093-0901EB7A-98C1-42B4-B13A-74F6D9357DBAQ47293465-1E9C0F13-CECA-4761-A5B5-73F61642190EQ47967042-F912C4CF-6C3D-4D14-839E-1CC63989621BQ50000124-5D2E86D8-082C-4B52-8B1B-1155E8F4D402Q50481005-D5A0FCAA-D322-4572-8874-6447FB94843CQ50535094-41599DCA-2FB0-44D0-9224-F3B88CD47D4CQ51483000-CA3B6E81-8547-4664-AF49-5EFF263BEB21Q53840503-ABC77400-5440-43E0-A5EE-64BDEE029366Q54961659-881F018F-D420-4B49-A154-EB4A2C80431C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Erythropoiesis-stimulating agent hyporesponsiveness.
@en
type
label
Erythropoiesis-stimulating agent hyporesponsiveness.
@en
prefLabel
Erythropoiesis-stimulating agent hyporesponsiveness.
@en
P2860
P1433
P1476
Erythropoiesis-stimulating agent hyporesponsiveness
@en
P2093
Carol A Pollock
Iain C Macdougall
P2860
P304
P356
10.1111/J.1440-1797.2007.00810.X
P577
2007-08-01T00:00:00Z